Filter by consultation end date
Showing 1 to 10 of 14
| Title | Consultation | Type | Consultation end date | Sort date |
|---|---|---|---|---|
| Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine [ID1059] | Appraisal consultation: 2 | Technology appraisal guidance | Type:23 April 2018 | 20180423 |
| Dupilumab for treating moderate to severe atopic dermatitis after topical treatments [ID1048] | Appraisal consultation | Technology appraisal guidance | Type:24 April 2018 | 20180424 |
| Pancreatitis: diagnosis and management | Draft guidance consultation | NICE guideline | Type:25 April 2018 | 20180425 |
| Cardiovascular disease: identifying and supporting people most at risk of dying early | Surveillance consultation | NICE guideline | Type:25 April 2018 | 20180425 |
| Cardiovascular disease prevention | Surveillance consultation | NICE guideline | Type:25 April 2018 | 20180425 |
| Ocrelizumab for treating relapsing multiple sclerosis [ID937] | Appraisal consultation | Technology appraisal guidance | Type:25 April 2018 | 20180425 |
| Alectinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer [ID925] | Appraisal consultation: 1 | Technology appraisal guidance | Type:26 April 2018 | 20180426 |
| Chronic heart failure in adults: diagnosis and management | Draft guidance consultation | NICE guideline | Type:26 April 2018 | 20180426 |
| Tumour profiling tests to guide adjuvant chemotherapy decisions in people with breast cancer (update of DG10) | Diagnostics consultation: 2 | Diagnostics guidance | Type:11 May 2018 | 20180511 |
| Emergency and acute medical care in over 16s | Quality standard consultation | Quality standard | Type:14 May 2018 | 20180514 |